Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Cost Savings"" wg kryterium: Temat


Tytuł :
Safety assessment of intraparenchymal central nervous system biopsies: Single institution healthcare value review.
Autorzy :
Mazur-Hart DJ; Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Yaghi NK; Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Goh JL; Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Lin Y; Neurological Surgery, Oregon Health & Science University, Portland, OR, United States.
Han S; Neurological Surgery, Oregon Health & Science University, Portland, OR, United States. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 May; Vol. 87, pp. 112-115. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Journal Article
MeSH Terms :
Health Care Costs*
Patient Safety*/economics
Brain Neoplasms/*diagnostic imaging
Cost Savings/*methods
Neuronavigation/*methods
Tomography, X-Ray Computed/*methods
Adult ; Aged ; Aged, 80 and over ; Biopsy/adverse effects ; Biopsy/economics ; Biopsy/methods ; Brain Neoplasms/economics ; Brain Neoplasms/pathology ; Cost Savings/economics ; Female ; Humans ; Intensive Care Units/economics ; Length of Stay/economics ; Male ; Middle Aged ; Neuronavigation/adverse effects ; Neuronavigation/economics ; Retrospective Studies ; Tomography, X-Ray Computed/economics ; Young Adult
Czasopismo naukowe
Tytuł :
A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
Autorzy :
Jang A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Nakashima L; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Ng T; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Fung M; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jiwani S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Schaff K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Suess J; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Goncalves R; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Jang D; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Kuik K; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Labelle S; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pow A; Provincial Pharmacy, BC Cancer, Vancouver, Canada.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Apr; Vol. 27 (3), pp. 635-643. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Multicenter Study; Pragmatic Clinical Trial
MeSH Terms :
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Cost Savings/*statistics & numerical data
Drug Costs/*statistics & numerical data
Drug Utilization Review/*statistics & numerical data
Antibodies, Monoclonal, Humanized/economics ; Antineoplastic Agents, Immunological/economics ; British Columbia/epidemiology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/economics ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Cost Savings/methods ; Cost-Benefit Analysis/methods ; Cost-Benefit Analysis/statistics & numerical data ; Dose-Response Relationship, Drug ; Drug Utilization Review/economics ; Drug Utilization Review/methods ; Female ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/economics ; Lung Neoplasms/epidemiology ; Male ; Melanoma/drug therapy ; Melanoma/economics ; Melanoma/epidemiology ; Retrospective Studies ; Skin Neoplasms/drug therapy ; Skin Neoplasms/economics ; Skin Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Autorzy :
Raimond VC; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Feldman WB; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.
Rome BN; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Kesselheim AS; Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital.; Harvard Medical School.
Pokaż więcej
Źródło :
The Milbank quarterly [Milbank Q] 2021 Mar; Vol. 99 (1), pp. 240-272.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Cost Savings*
Government Regulation*
Medicare Part D/*economics
Prescription Drugs/*economics
Costs and Cost Analysis ; Drug Costs/legislation & jurisprudence ; France ; Insurance Coverage ; Legislation, Drug ; United States
Czasopismo naukowe
Tytuł :
Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis.
Autorzy :
Gilmartin C; Management Sciences for Health, Arlington, VA, USA. Electronic address: .
Nonvignon J; University of Ghana School of Public Health, Accra, Ghana.
Cairns M; London School of Hygiene & Tropical Medicine, London, UK.
Milligan P; London School of Hygiene & Tropical Medicine, London, UK.
Bocoum F; Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
Winskill P; MRC Centre of Global Infectious Disease Analysis, Imperial College London, London, UK.
Moroso D; Malaria Consortium Regional Office, Kampala, Uganda.
Collins D; Management Sciences for Health, Arlington, VA, USA; Boston University School of Public Health, Boston, MA, USA.
Pokaż więcej
Źródło :
The Lancet. Global health [Lancet Glob Health] 2021 Feb; Vol. 9 (2), pp. e199-e208.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoprevention*/economics
Cost Savings*
Cost-Benefit Analysis*
Quality-Adjusted Life Years*
Seasons*
Antimalarials/*therapeutic use
Malaria/*prevention & control
Africa ; Child ; Child, Preschool ; Humans ; Infant
Czasopismo naukowe
Tytuł :
Cost Savings of Frequent, Concise Skills Competency Training in the Emergency Department.
Autorzy :
Kaiafas KN
Bennett RC
Pokaż więcej
Źródło :
Journal of emergency nursing [J Emerg Nurs] 2021 Jan; Vol. 47 (1), pp. 181-185. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Competence*
Cost Savings*
Emergency Nursing/*education
Emergency Service, Hospital/*economics
Hospitals, Military/*economics
Inservice Training/*economics
Humans
Czasopismo naukowe
Tytuł :
Iraqi regulatory authority current system and experience with biosimilars.
Autorzy :
Al-Kinani KK; College of Pharmacy, University of Baghdad, Baghdad, Iraq. Electronic address: .
Ibrahim MJ; College of Medicine, University of Baghdad, Baghdad, Iraq.
Al-Zubaidi RF; Directorate of Forensic Medicine, Ministry of Health and Environment, Baghdad, Iraq.
Younus MM; Iraqi Pharmacovigilance Center, Ministry of Health and Environment, Baghdad, Iraq.
Ramadhan SH; National Center for Drug Control and Research, Ministry of Health and Environment, Baghdad, Iraq.
Kadhim HJ; Registration Department, Ministry of Health and Environment, Baghdad, Iraq.
Challand R; Challand Biosimilar Consulting Ltd, United Kingdom.
Pokaż więcej
Źródło :
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2020 Nov; Vol. 117, pp. 104768. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pharmacovigilance*
Biosimilar Pharmaceuticals/*standards
Cost Savings/*legislation & jurisprudence
Drug Approval/*legislation & jurisprudence
Animals ; Biosimilar Pharmaceuticals/economics ; Cost Savings/methods ; Drug Approval/methods ; Humans
Czasopismo naukowe
Tytuł :
All-Polyethylene Tibia: An Opportunity for Value-Based Care in Bundled Reimbursement Initiatives.
Autorzy :
Ryan SP
Steele JR
Plate JF
Attarian DE
Seyler TM
Bolognesi MP
Wellman SS
Pokaż więcej
Źródło :
Orthopedics [Orthopedics] 2021 Jan 01; Vol. 44 (1), pp. e114-e118. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji :
Journal Article
MeSH Terms :
Cost Savings*
Arthroplasty, Replacement, Knee/*economics
Knee Prosthesis/*economics
Medicare/*economics
Tibia/*surgery
Aged ; Centers for Medicare and Medicaid Services, U.S. ; Female ; Hospital Costs ; Humans ; Male ; Polyethylene ; Reimbursement Mechanisms ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Broken Promises - How Medicare Part D Has Failed to Deliver Savings to Older Adults.
Autorzy :
Dusetzina SB; From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Comprehensive Cancer Center, Nashville (S.B.D.); the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill (B.M.); and the Department of Health Care Policy, Harvard Medical School (N.L.K., H.A.H.), and the Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.) - both in Boston.
Muluneh B; From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Comprehensive Cancer Center, Nashville (S.B.D.); the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill (B.M.); and the Department of Health Care Policy, Harvard Medical School (N.L.K., H.A.H.), and the Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.) - both in Boston.
Keating NL; From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Comprehensive Cancer Center, Nashville (S.B.D.); the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill (B.M.); and the Department of Health Care Policy, Harvard Medical School (N.L.K., H.A.H.), and the Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.) - both in Boston.
Huskamp HA; From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Comprehensive Cancer Center, Nashville (S.B.D.); the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill (B.M.); and the Department of Health Care Policy, Harvard Medical School (N.L.K., H.A.H.), and the Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.) - both in Boston.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Dec 10; Vol. 383 (24), pp. 2299-2301. Date of Electronic Publication: 2020 Dec 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cost Savings*
Antineoplastic Agents/*economics
Drugs, Generic/*economics
Health Expenditures/*trends
Imatinib Mesylate/*economics
Medicare Part D/*economics
Prescription Fees/*trends
Aged ; Health Care Reform/legislation & jurisprudence ; Health Expenditures/legislation & jurisprudence ; Humans ; Prescription Fees/legislation & jurisprudence ; United States
Czasopismo naukowe
Tytuł :
Machine Learning Improves the Identification of Individuals With Higher Morbidity and Avoidable Health Costs After Acute Coronary Syndromes.
Autorzy :
de Carvalho LSF; Clarity Healthcare Intelligence, Jundiaí, SP, Brazil; Cardiology Department, State University of Campinas (Unicamp), Campinas, SP, Brazil; Laboratory of Data for Quality of Care and Outcomes Research, Institute of Strategic Management in Healthcare Brasília, DF, Brazil; Escola Superior de Ciências da Saúde, Brasília, DF, Brazil. Electronic address: .
Gioppato S; Cardiology Department, State University of Campinas (Unicamp), Campinas, SP, Brazil; Vera Cruz Hospital, Campinas, SP, Brazil.
Fernandez MD; Clarity Healthcare Intelligence, Jundiaí, SP, Brazil; Faculty of Electrical Engineering and Computation, Unicamp, Campinas, SP, Brazil.
Trindade BC; School of Civil and Environmental Engineering, Cornell Univ., Ithaca, NY, USA.
Silva JCQE; Laboratory of Data for Quality of Care and Outcomes Research, Institute of Strategic Management in Healthcare Brasília, DF, Brazil; Escola Superior de Ciências da Saúde, Brasília, DF, Brazil.
Miranda RGS; Secretariat of Foreign Trade, Ministry of the Economy, Brasília, DF, Brazil.
de Souza JRM; Laboratory of Data for Quality of Care and Outcomes Research, Institute of Strategic Management in Healthcare Brasília, DF, Brazil.
Nadruz W; Laboratory of Data for Quality of Care and Outcomes Research, Institute of Strategic Management in Healthcare Brasília, DF, Brazil.
Avila SEF; Institute of Computing, Unicamp, Campinas, SP, Brazil.
Sposito AC; Cardiology Department, State University of Campinas (Unicamp), Campinas, SP, Brazil.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Dec; Vol. 23 (12), pp. 1570-1579. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Machine Learning*
Acute Coronary Syndrome/*economics
Cost Savings/*statistics & numerical data
Health Care Costs/*statistics & numerical data
Acute Coronary Syndrome/complications ; Aged ; Cost Savings/economics ; Female ; Humans ; Male ; Morbidity ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Return on investment of the Enhanced Recovery After Surgery (ERAS) multiguideline, multisite implementation in Alberta, Canada.
Autorzy :
Thanh N; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Nelson A; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Wang X; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Faris P; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Wasylak T; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Gramlich L; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Nelson G; From the Strategic Clinical Networks, Alberta Health Services, Edmonton and Calgary, Alta. (Thanh, Wasylak); the Surgery Strategic Clinical Network, Alberta Health Services, Calgary, Alta. (A. Nelson); Analytics, Data Integration, Measurement and Reporting, Alberta Health Services, Edmonton and Calgary, Alta. (Wang, Faris); the Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta. (Gramlich); and the Section of Gynecologic Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alta. (G. Nelson).
Pokaż więcej
Źródło :
Canadian journal of surgery. Journal canadien de chirurgie [Can J Surg] 2020 Nov 30; Vol. 63 (6), pp. E542-E550. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Cost Savings/*statistics & numerical data
Enhanced Recovery After Surgery/*standards
Health Plan Implementation/*economics
Surgical Procedures, Operative/*rehabilitation
Aged ; Alberta/epidemiology ; Cost Savings/economics ; Female ; Humans ; Length of Stay/economics ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; Patient Readmission/economics ; Patient Readmission/statistics & numerical data ; Postoperative Complications/economics ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Practice Guidelines as Topic ; Surgical Procedures, Operative/adverse effects
Czasopismo naukowe
Tytuł :
Drug cost savings in phase III hematological oncology clinical trials in a university hospital.
Autorzy :
Herledan C; Clinical Oncology Pharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, Pierre-Bénite, France.; EMR3738 Therapeutic Targeting in Oncology, Université de Lyon, Lyon, France.
Ranchon F; Clinical Oncology Pharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, Pierre-Bénite, France.; EMR3738 Therapeutic Targeting in Oncology, Université de Lyon, Lyon, France.
Schwiertz V; Clinical Oncology Pharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, Pierre-Bénite, France.
Baudouin A; Clinical Oncology Pharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, Pierre-Bénite, France.
Karlin L; Department of Hematology, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
Ghesquières H; Department of Hematology, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Faculté de Médecine Lyon-Sud Charles Mérieux, INSERM 1052, CNRS 5286, Université Claude Bernard, Université de Lyon, Pierre Bénite, France.
Salles G; Department of Hematology, Groupement Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Faculté de Médecine Lyon-Sud Charles Mérieux, INSERM 1052, CNRS 5286, Université Claude Bernard, Université de Lyon, Pierre Bénite, France.
Rioufol C; Clinical Oncology Pharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Sud, Pierre-Bénite, France.; EMR3738 Therapeutic Targeting in Oncology, Université de Lyon, Lyon, France.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 576-583. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Cost Savings*
Cost-Benefit Analysis*
Antineoplastic Combined Chemotherapy Protocols/*economics
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hematologic Neoplasms/*drug therapy
Hematologic Neoplasms/*economics
Hospitals, University/*economics
Humans ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Health economic evaluation of a clinical pharmacist's intervention on the appropriate use of devices and cost savings: A pilot study.
Autorzy :
Chasseigne V; Department of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France. Electronic address: .
Bouvet S; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France; Department of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, Nimes University Hospital, University of Montpellier, Nimes, France.
Chkair S; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France; Department of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, Nimes University Hospital, University of Montpellier, Nimes, France.
Buisson M; Department of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
Richard M; Department of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France.
de Tayrac R; Department of Obstetrics and Gynecology, Nimes University Hospital, University of Montpellier, Nimes, France.
Bertrand MM; Department of Visceral and Digestive Surgery, Nimes University Hospital, University of Montpellier, Nimes, France.
Castelli C; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France; Department of Biostatistics, Epidemiology, Public Health and Innovation in Methodology, Nimes University Hospital, University of Montpellier, Nimes, France.
Kinowski JM; Department of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France.
Leguelinel-Blache G; Department of Pharmacy, Nimes University Hospital, University of Montpellier, Nimes, France; UPRES EA2415, Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, Clinical Research University Institute, University of Montpellier, Montpellier, France; Department of Law and Health Economics, Faculty of Pharmacy, University of Montpellier, Montpellier, France.
Pokaż więcej
Źródło :
International journal of surgery (London, England) [Int J Surg] 2020 Oct; Vol. 82, pp. 143-148. Date of Electronic Publication: 2020 Aug 29.
Typ publikacji :
Journal Article
MeSH Terms :
Cost Savings*
Equipment and Supplies*/economics
Operating Rooms*/economics
Pharmacists*/economics
Hospitals, University ; Humans ; Pilot Projects ; Prospective Studies
Czasopismo naukowe
Tytuł :
Savings or Selection? Initial Spending Reductions in the Medicare Shared Savings Program and Considerations for Reform.
Autorzy :
McWILLIAMS JM; Harvard Medical School.; Brigham and Women's Hospital.
Hatfield LA; Harvard Medical School.
Landon BE; Harvard Medical School.; Beth Israel Deaconess Medical Center.
Chernew ME; Harvard Medical School.
Pokaż więcej
Źródło :
The Milbank quarterly [Milbank Q] 2020 Sep; Vol. 98 (3), pp. 847-907. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost Savings*/economics
Cost Savings*/methods
Cost Savings*/statistics & numerical data
Cost Sharing/*economics
Medicare/*economics
Accountable Care Organizations/economics ; Accountable Care Organizations/organization & administration ; Accountable Care Organizations/statistics & numerical data ; Aged ; Cost Sharing/methods ; Cost Sharing/statistics & numerical data ; Female ; Humans ; Insurance Claim Review ; Male ; Medicare/organization & administration ; United States
Czasopismo naukowe
Tytuł :
Costs and Outcomes of Medicare Advantage and Traditional Medicare Beneficiaries After Total Hip and Knee Arthroplasty.
Autorzy :
Yayac MF; From the Rothman Orthopaedic Institute at Thomas Jefferson University (Dr. Yayac, Mr. Janiec, Dr. Courtney), Philadelphia, PA, and the Sidney Kimmel Medical College (Ms. Harrer), Thomas Jefferson University, Philadelphia, PA.
Harrer SL
Janiec DA
Courtney PM
Pokaż więcej
Źródło :
The Journal of the American Academy of Orthopaedic Surgeons [J Am Acad Orthop Surg] 2020 Oct 15; Vol. 28 (20), pp. e910-e916.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Cost Savings*
Arthroplasty, Replacement, Hip/*economics
Arthroplasty, Replacement, Knee/*economics
Insurance Benefits/*economics
Medicare/*economics
Medicare Part C/*economics
Aged ; Arthroplasty, Replacement, Hip/rehabilitation ; Arthroplasty, Replacement, Knee/rehabilitation ; Female ; Humans ; Length of Stay ; Male ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Preliminary Findings After Nonoperative Management of Traumatic Cervical Spinal Cord Injury on a Background of Degenerative Disc Disease: Providing Optimum Patient Care and Costs Saving in a Nigerian Setting.
Autorzy :
Adedigba JA; Deparment of Neurological Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA. Electronic address: .
Oremakinde AA; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Huang B; Deparment of Neurological Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Maulucci CM; Deparment of Neurological Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Malomo AO; Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria; Department of Neurological Surgery, University of Ibadan, Ibadan, Nigeria.
Shokunbi TM; Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria; Department of Neurological Surgery, University of Ibadan, Ibadan, Nigeria.
Adeolu AA; Department of Neurological Surgery, University College Hospital, Ibadan, Nigeria; Department of Neurological Surgery, University of Ibadan, Ibadan, Nigeria.
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2020 Oct; Vol. 142, pp. 246-254. Date of Electronic Publication: 2020 Jul 12.
Typ publikacji :
Journal Article
MeSH Terms :
Disease Management*
Cervical Vertebrae/*diagnostic imaging
Cost Savings/*methods
Intervertebral Disc Degeneration/*therapy
Patient Care/*methods
Spinal Cord Injuries/*therapy
Adult ; Aged ; Cervical Cord/diagnostic imaging ; Cervical Cord/injuries ; Cohort Studies ; Cost Savings/economics ; Female ; Humans ; Intervertebral Disc Degeneration/diagnostic imaging ; Intervertebral Disc Degeneration/economics ; Intervertebral Disc Degeneration/epidemiology ; Male ; Middle Aged ; Nigeria/epidemiology ; Patient Care/economics ; Prospective Studies ; Spinal Cord Injuries/diagnostic imaging ; Spinal Cord Injuries/economics ; Spinal Cord Injuries/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings.
Autorzy :
Fukudo M; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Ishikawa R; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Mishima K; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Ono T; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Matsumoto S; Center for Advanced Research and Education, Asahikawa Medical University, Asahikawa, Japan.
Tasaki Y; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Pokaż więcej
Źródło :
JCO oncology practice [JCO Oncol Pract] 2020 Oct; Vol. 16 (10), pp. e1134-e1142. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost Savings*
Nivolumab/*economics
Pharmaceutical Preparations/*supply & distribution
Drug Compounding ; Drug Stability ; Japan
Czasopismo naukowe
Tytuł :
Bundled Payment Plans Are Associated With Notable Cost Savings for Ambulatory Outpatient Total Shoulder Arthroplasty.
Autorzy :
Walters JD; From the Department of Orthopaedic Surgery and Biomedical Engineering (Dr. Walters, Dr. Brolin, Dr. Azar, Dr. Smith, Dr. Throckmorton), University of Tennessee-Campbell Clinic, Memphis, TN, and the University of Tennessee Health Science Center (Dr. Walsh), College of Medicine, Department of Emergeny Medicine, Memphis, TN.
Walsh RN
Smith RA
Brolin TJ
Azar FM
Throckmorton TW
Pokaż więcej
Źródło :
The Journal of the American Academy of Orthopaedic Surgeons [J Am Acad Orthop Surg] 2020 Oct 01; Vol. 28 (19), pp. 795-801.
Typ publikacji :
Journal Article
MeSH Terms :
Cost Savings*
Health Expenditures*
Outpatients*
Ambulatory Care/*economics
Arthroplasty, Replacement, Shoulder/*economics
Fee-for-Service Plans/*economics
Patient Care Bundles/*economics
Aged ; Humans ; Male ; Middle Aged ; Time Factors
Czasopismo naukowe
Tytuł :
Microplegia vs 4:1 Blood Cardioplegia: Effectiveness and Cost Savings in Complex Cardiac Operations.
Autorzy :
Borden RA 2nd; Heart, Vascular, and Thoracic Institute, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland Clinic, Cleveland, Ohio.
Ball C; Perfusion Services, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Grady PM; Perfusion Services, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Toth AJ; Department of Quantitative Health Sciences, Research Institute, Cleveland Clinic, Cleveland, Ohio.
Lober C; Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio.
Bakaeen FG; Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio; Aorta Center, Cleveland Clinic, Cleveland, Ohio.
Tong MZ; Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio; Aorta Center, Cleveland Clinic, Cleveland, Ohio.
Soltesz EG; Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio; Aorta Center, Cleveland Clinic, Cleveland, Ohio.
Blackstone EH; Department of Quantitative Health Sciences, Research Institute, Cleveland Clinic, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.
Roselli EE; Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio; Aorta Center, Cleveland Clinic, Cleveland, Ohio. Electronic address: .
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2020 Oct; Vol. 110 (4), pp. 1216-1224. Date of Electronic Publication: 2020 Mar 08.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost Savings*
Health Care Costs*
Cardiac Surgical Procedures/*economics
Heart Arrest, Induced/*methods
Postoperative Complications/*epidemiology
Aged ; Cardiac Surgical Procedures/adverse effects ; Cardioplegic Solutions/administration & dosage ; Cardiopulmonary Bypass ; Female ; Heart Arrest, Induced/economics ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Postoperative Complications/blood ; Propensity Score ; Retrospective Studies ; Treatment Outcome ; Troponin T/blood
Czasopismo naukowe
Tytuł :
Cost Impact of a Pharmacist-Driven Medication Reconciliation Program during Transitions to Long-Term Care and Retirement Homes.
Autorzy :
O'Donnell D; Director of clinical research at Medical Pharmacies Group Limited in Markham, ON. Denis can be reached by e-mail at .
Beaton C; HQO IDEAS alumnus, was vice president of clinical innovations & quality improvement at Medical Pharmacies Group Limited in Markham, ON.
Liang J; A clinical data coordinator at Medical Pharmacies Group Limited in Markham, ON.
Basu K; A senior economic advisor at Health Canada in Ottawa, ON.
Hum M; A clinical pharmacist for the BOOMR program at Medical Pharmacies Group Limited in Markham, ON.
Propp A; A clinical pharmacist for the BOOMR program at Medical Pharmacies Group Limited in Markham, ON.
Yanni L; Manager of Clinical Education and Quality Improvement Programs at Medical Pharmacies Group Limited in Markham, ON.
Chen Y; A clinical pharmacist with the Medication Reconciliation Program at Bridgepoint Active Healthcare in Toronto, ON.
Ghafari P; Manager of Clinical Client Care Services (including the BOOMR program) at Medical Pharmacies Group Limited in Markham, ON.
Pokaż więcej
Źródło :
Healthcare quarterly (Toronto, Ont.) [Healthc Q] 2020 Oct; Vol. 23 (3), pp. 34-40.
Typ publikacji :
Journal Article
MeSH Terms :
Cost Savings*
Medication Reconciliation/*economics
Drug-Related Side Effects and Adverse Reactions/prevention & control ; Homes for the Aged ; Hospitalization/economics ; Humans ; Long-Term Care ; Ontario ; Pharmaceutical Preparations/economics ; Pharmacists ; Polypharmacy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on generics.
Autorzy :
Giraud JS; Hospital Pharmacy, Foch Hospital, Suresnes, France.
Doisne M; Hospital Pharmacy, Foch Hospital, Suresnes, France.
Chan Hew Wai A; Hospital Pharmacy, Foch Hospital, Suresnes, France.
Majerholc C; HIV Department, Foch Hospital, Suresnes, France.
Fourn E; HIV Department, Foch Hospital, Suresnes, France.
Sejean K; Hospital Pharmacy, Foch Hospital, Suresnes, France.
Trichereau J; Biostatistics Department, Foch Hospital, Suresnes, France.
Bonan B; Hospital Pharmacy, Foch Hospital, Suresnes, France.
Zucman D; HIV Department, Foch Hospital, Suresnes, France.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 25; Vol. 15 (9), pp. e0239704. Date of Electronic Publication: 2020 Sep 25 (Print Publication: 2020).
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Cost Savings*
Patient Satisfaction*
Anti-HIV Agents/*economics
Drugs, Generic/*economics
Tablets/*economics
Adult ; Aged ; Anti-HIV Agents/administration & dosage ; Drug Utilization/economics ; Drugs, Generic/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Practice Guidelines as Topic ; Tablets/administration & dosage
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies